store at low temperature
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Larotaxel (XRP9881) is a taxane analogue that has anticancer activity, exerts its cytotoxic effects by promoting tubulin assembly and stabilizing microtubules, and ultimately induces cell death through apoptosis. Larotaxel (XRP9881) is a compound that crosses the blood-brain barrier and has a higher affinity for Docetaxel than P-glycoprotein 1, which can be used to study breast and bladder cancer.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 128.00 | |
5 mg | In stock | $ 326.00 | |
10 mg | In stock | $ 486.00 | |
25 mg | In stock | $ 778.00 | |
50 mg | In stock | $ 1,060.00 |
Description | Larotaxel (XRP9881) is a taxane analogue that has anticancer activity, exerts its cytotoxic effects by promoting tubulin assembly and stabilizing microtubules, and ultimately induces cell death through apoptosis. Larotaxel (XRP9881) is a compound that crosses the blood-brain barrier and has a higher affinity for Docetaxel than P-glycoprotein 1, which can be used to study breast and bladder cancer. |
Synonyms | XRP9881 |
Molecular Weight | 831.9 |
Formula | C45H53NO14 |
CAS No. | 156294-36-9 |
store at low temperature
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (60.10 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Larotaxel 156294-36-9 Membrane transporter/Ion channel Neuroscience P-gp XRP9881 XRP 9881 XRP-9881 inhibitor inhibit